CLIA Kit for Triggering Receptor Expressed On Myeloid Cells 1 (TREM1)

CD354; Triggering Receptor Expressed On Monocytes-1

  • CLIA Kit for Triggering Receptor Expressed On Myeloid Cells 1 (TREM1) Packages (Simulation)
  • CLIA Kit for Triggering Receptor Expressed On Myeloid Cells 1 (TREM1) Packages (Simulation)
  • CLIA Kit for Triggering Receptor Expressed On Myeloid Cells 1 (TREM1) Results demonstration
  • SCA213Hu.jpg Typical Standard Curve
  • Certificate ISO9001: 2008, ISO13485: 2003 Registered

Specificity of the CLIA Kit for Triggering Receptor Expressed On Myeloid Cells 1 (TREM1)

This assay has high sensitivity and excellent specificity for detection of Triggering Receptor Expressed On Myeloid Cells 1 (TREM1).
No significant cross-reactivity or interference between Triggering Receptor Expressed On Myeloid Cells 1 (TREM1) and analogues was observed.

Recovery of the CLIA Kit for Triggering Receptor Expressed On Myeloid Cells 1 (TREM1)

Matrices listed below were spiked with certain level of recombinant Triggering Receptor Expressed On Myeloid Cells 1 (TREM1) and the recovery rates were calculated by comparing the measured value to the expected amount of Triggering Receptor Expressed On Myeloid Cells 1 (TREM1) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 84-101 95
EDTA plasma(n=5) 95-103 98
heparin plasma(n=5) 80-90 84

Precision of the CLIA Kit for Triggering Receptor Expressed On Myeloid Cells 1 (TREM1)

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Triggering Receptor Expressed On Myeloid Cells 1 (TREM1) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Triggering Receptor Expressed On Myeloid Cells 1 (TREM1) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity of the CLIA Kit for Triggering Receptor Expressed On Myeloid Cells 1 (TREM1)

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Triggering Receptor Expressed On Myeloid Cells 1 (TREM1) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 91-105% 85-97% 78-91% 95-102%
EDTA plasma(n=5) 88-95% 98-105% 93-101% 84-99%
heparin plasma(n=5) 81-88% 88-104% 89-102% 95-102%

Stability of the CLIA Kit for Triggering Receptor Expressed On Myeloid Cells 1 (TREM1)

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Assay procedure summary of the CLIA Kit for Triggering Receptor Expressed On Myeloid Cells 1 (TREM1)

1. Prepare all reagents, samples and standards;
2. Add 100µL standard or sample to each well. Incubate 1 hours at 37°C;
3. Aspirate and add 100µL prepared Detection Reagent A. Incubate 1 hour at 37°C;
4. Aspirate and wash 3 times;
5. Add 100µL prepared Detection Reagent B. Incubate 30 minutes at 37°C;
6. Aspirate and wash 5 times;
7. Add 100µL Substrate Solution. Incubate 10 minutes at 37°C;
8. Read RLU value immediately.

Test principle of the CLIA Kit for Triggering Receptor Expressed On Myeloid Cells 1 (TREM1)

The microplate provided in this kit has been pre-coated with an antibody specific to Triggering Receptor Expressed On Myeloid Cells 1 (TREM1). Standards or samples are then added to the appropriate microplate wells with a biotin-conjugated antibody specific to Triggering Receptor Expressed On Myeloid Cells 1 (TREM1). Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. Then the mixture of substrate A and B is added to generate glow light emission kinetics. Upon plate development, the intensity of the emitted light is proportional to the Triggering Receptor Expressed On Myeloid Cells 1 (TREM1) level in the sample or standard.;

Related products

Catalog No. Organism species: Homo sapiens (Human) Applications (RESEARCH USE ONLY!)
EPA213Hu61 Eukaryotic Triggering Receptor Expressed On Myeloid Cells 1 (TREM1) Positive Control; Immunogen; SDS-PAGE; WB.
APA213Hu61 Active Triggering Receptor Expressed On Myeloid Cells 1 (TREM1) Cell culture; Activity Assays.
RPA213Hu01 Recombinant Triggering Receptor Expressed On Myeloid Cells 1 (TREM1) Positive Control; Immunogen; SDS-PAGE; WB.
PAA213Hu01 Polyclonal Antibody to Triggering Receptor Expressed On Myeloid Cells 1 (TREM1) WB; IHC; ICC; IP.
FAA213Hu01 Anti-Triggering Receptor Expressed On Myeloid Cells 1 (TREM1) Polyclonal Antibody Flow cytometry.
MAA213Hu22 Monoclonal Antibody to Triggering Receptor Expressed On Myeloid Cells 1 (TREM1) WB; IHC; ICC; IP.
SEA213Hu ELISA Kit for Triggering Receptor Expressed On Myeloid Cells 1 (TREM1) Enzyme-linked immunosorbent assay for Antigen Detection.
SCA213Hu CLIA Kit for Triggering Receptor Expressed On Myeloid Cells 1 (TREM1) Chemiluminescent immunoassay for Antigen Detection.
LMA213Hu Multiplex Assay Kit for Triggering Receptor Expressed On Myeloid Cells 1 (TREM1) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.
GUESTBOOK